Search research articles
Contact Us
Filters
Showing results (71-80 of 221) with videos related to
Page
of 23
Sort By:
Pharmacotherapy
|
July 31, 2013
Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals
Susan L Davis, Marc H Scheetz, John A Bosso, et al.
The Journal of Antimicrobial Chemotherapy
|
May 31, 2022
Does calculation method matter for targeting vancomycin area under the curve?
Jack Chang, Dhara Patel, Ana Vega, et al.
Pharmacotherapy
|
September 20, 2011
Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model
Marc H Scheetz, Maureen K Bolon, John S Esterly, et al.
Expert Review of Anti-Infective Therapy
|
February 27, 2016
Carbapenem susceptibility breakpoints, clinical implications with the moving target
J Nicholas O'Donnell, Cristina M Miglis, Jane Y Lee, et al.
Antimicrobial Agents and Chemotherapy
|
July 11, 2012
Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification
John S Esterly, Jamie Wagner, Milena M McLaughlin, et al.
International Journal of Antimicrobial Agents
|
April 13, 2010
Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients
E Paul O'Donnell, Kimberly K Scarsi, Marc H Scheetz, et al.
ACR Open Rheumatology
|
July 30, 2020
A Pharmacokinetics-Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID-19 Pandemic
Marc H Scheetz, Maximilian F Konig, Philip C Robinson, et al.
Antimicrobial Agents and Chemotherapy
|
April 10, 2024
Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections
Andrew S Haynes, Zixuan Wei, Peter Anderson, et al.
Clinical Pharmacokinetics
|
May 30, 2020
Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study
Ahmed A Mahmoud, Sean N Avedissian, Abbas Al-Qamari, et al.
Antimicrobial Agents and Chemotherapy
|
September 11, 2013
Pharmacodynamic target attainment for various ceftazidime dosing schemes in high-flux hemodialysis
Angela S Loo, Michael Neely, Evan J Anderson, et al.
Page
of 23
Search research articles
Search
Showing results (71-80 of 221) with videos related to
Sort By:
Page
of 23
Pharmacotherapy
|
July 31, 2013
Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals
Susan L Davis, Marc H Scheetz, John A Bosso, et al.
The Journal of Antimicrobial Chemotherapy
|
May 31, 2022
Does calculation method matter for targeting vancomycin area under the curve?
Jack Chang, Dhara Patel, Ana Vega, et al.
Pharmacotherapy
|
September 20, 2011
Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model
Marc H Scheetz, Maureen K Bolon, John S Esterly, et al.
Expert Review of Anti-Infective Therapy
|
February 27, 2016
Carbapenem susceptibility breakpoints, clinical implications with the moving target
J Nicholas O'Donnell, Cristina M Miglis, Jane Y Lee, et al.
Antimicrobial Agents and Chemotherapy
|
July 11, 2012
Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification
John S Esterly, Jamie Wagner, Milena M McLaughlin, et al.
International Journal of Antimicrobial Agents
|
April 13, 2010
Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients
E Paul O'Donnell, Kimberly K Scarsi, Marc H Scheetz, et al.
ACR Open Rheumatology
|
July 30, 2020
A Pharmacokinetics-Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID-19 Pandemic
Marc H Scheetz, Maximilian F Konig, Philip C Robinson, et al.
Antimicrobial Agents and Chemotherapy
|
April 10, 2024
Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections
Andrew S Haynes, Zixuan Wei, Peter Anderson, et al.
Clinical Pharmacokinetics
|
May 30, 2020
Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study
Ahmed A Mahmoud, Sean N Avedissian, Abbas Al-Qamari, et al.
Antimicrobial Agents and Chemotherapy
|
September 11, 2013
Pharmacodynamic target attainment for various ceftazidime dosing schemes in high-flux hemodialysis
Angela S Loo, Michael Neely, Evan J Anderson, et al.
Page
of 23